Search research articles
Contact Us
Filters
Showing results (451-460 of 469) with videos related to
Page
of 47
Sort By:
Signal Transduction and Targeted Therapy
|
March 17, 2023
Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study
Guo-Ming Shi, Xiao-Yong Huang, Dong Wu, et al.
Chinese Medical Journal
|
November 15, 2017
Shanghai Score: A Prognostic and Adjuvant Treatment-evaluating System Constructed for Chinese Patients with Hepatocellular Carcinoma after Curative Resection
Hui-Chuan Sun, Lu Xie, Xin-Rong Yang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
September 28, 2024
TRPC3/6 Channels Mediate Mechanical Pain Hypersensitivity via Enhancement of Nociceptor Excitability and of Spinal Synaptic Transmission
Zhi-Chuan Sun, Wen-Juan Han, Zhi-Wei Dou, et al.
Iscience
|
September 30, 2018
Two Likely Auto-Tetraploidization Events Shaped Kiwifruit Genome and Contributed to Establishment of the Actinidiaceae Family
Jin-Peng Wang, Ji-Gao Yu, Jing Li, et al.
BMC Cancer
|
May 9, 2023
Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study
Cheng Huang, Xiao-Dong Zhu, Ying-Hao Shen, et al.
Hepatology (Baltimore, Md.)
|
January 6, 2015
Ubiquitin-specific protease 7 accelerates p14(ARF) degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progression
Jia-Bin Cai, Guo-Ming Shi, Zhao-Ru Dong, et al.
Future Oncology (London, England)
|
August 8, 2024
A plain language summary of the results from the phase 2b HERIZON-BTC-01 study of zanidatamab in participants with HER2-amplified biliary tract cancer
James J Harding, Jia Fan, Do-Youn Oh, et al.
Trials
|
December 13, 2021
Atorvastatin combined with dexamethasone in chronic subdural haematoma (ATOCH II): study protocol for a randomized controlled trial
Rong Cai Jiang, Dong Wang, Shi Guang Zhao, et al.
Liver Cancer
|
August 21, 2023
Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study
Bin Xu, San-Yuan Dong, Xue-Li Bai, et al.
Nature Communications
|
July 3, 2021
Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma
Yun-Fan Sun, Liang Wu, Shi-Ping Liu, et al.
Page
of 47
Search research articles
Search
Showing results (451-460 of 469) with videos related to
Sort By:
Page
of 47
Signal Transduction and Targeted Therapy
|
March 17, 2023
Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study
Guo-Ming Shi, Xiao-Yong Huang, Dong Wu, et al.
Chinese Medical Journal
|
November 15, 2017
Shanghai Score: A Prognostic and Adjuvant Treatment-evaluating System Constructed for Chinese Patients with Hepatocellular Carcinoma after Curative Resection
Hui-Chuan Sun, Lu Xie, Xin-Rong Yang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
September 28, 2024
TRPC3/6 Channels Mediate Mechanical Pain Hypersensitivity via Enhancement of Nociceptor Excitability and of Spinal Synaptic Transmission
Zhi-Chuan Sun, Wen-Juan Han, Zhi-Wei Dou, et al.
Iscience
|
September 30, 2018
Two Likely Auto-Tetraploidization Events Shaped Kiwifruit Genome and Contributed to Establishment of the Actinidiaceae Family
Jin-Peng Wang, Ji-Gao Yu, Jing Li, et al.
BMC Cancer
|
May 9, 2023
Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study
Cheng Huang, Xiao-Dong Zhu, Ying-Hao Shen, et al.
Hepatology (Baltimore, Md.)
|
January 6, 2015
Ubiquitin-specific protease 7 accelerates p14(ARF) degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progression
Jia-Bin Cai, Guo-Ming Shi, Zhao-Ru Dong, et al.
Future Oncology (London, England)
|
August 8, 2024
A plain language summary of the results from the phase 2b HERIZON-BTC-01 study of zanidatamab in participants with HER2-amplified biliary tract cancer
James J Harding, Jia Fan, Do-Youn Oh, et al.
Trials
|
December 13, 2021
Atorvastatin combined with dexamethasone in chronic subdural haematoma (ATOCH II): study protocol for a randomized controlled trial
Rong Cai Jiang, Dong Wang, Shi Guang Zhao, et al.
Liver Cancer
|
August 21, 2023
Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study
Bin Xu, San-Yuan Dong, Xue-Li Bai, et al.
Nature Communications
|
July 3, 2021
Dissecting spatial heterogeneity and the immune-evasion mechanism of CTCs by single-cell RNA-seq in hepatocellular carcinoma
Yun-Fan Sun, Liang Wu, Shi-Ping Liu, et al.
Page
of 47